Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis. - Devi R; Dadwal P; Sharma N; Singh A; Arora A (Inflammopharmacology, 2026)